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H-6720, Szeged, HungaryAbstract—Glucose concentration changes in the nucleus
tractus solitarius (NTS) aﬀect visceral function and metabo-
lism by inﬂuencing central vagal circuits, especially inhibi-
tory, GABAergic NTS neurons. Acutely elevated glucose
can alter NTS neuron activity, and prolonged hyperglycemia
and hypoinsulemia in animal models of type 1 diabetes
results in plasticity of neural responses in the NTS. NTS neu-
rons contributing to metabolic regulation therefore act as
central glucose sensors and are functionally altered in type
1 diabetes. Glucokinase (GCK) mediates cellular utilization
of glucose, linking increased glucose concentration to
excitability changesmediated by ATP-sensitive K+ channels
(KATP). Using quantitative reverse transcriptase-polymerase
chain reaction (RT-PCR), Western blot, and in vitro electro-
physiology, we tested the hypothesis that changes in GCK
expression in the NTS accompany the development of
diabetes symptoms in the streptozotocin (STZ)-treated
mouse model of type 1 diabetes. After several days of
hyperglycemia in STZ-treated mice, RNA expression of
GCK, but not Kir6.2 or SUR1, was decreased versus controls
in the dorsal vagal complex. Electrophysiological record-
ings in vitro indicated that neural responses to acute
hyperglycemia, and synaptic responsiveness to blockade
of GCK with glucosamine, were attenuated in GABAergic
NTS neurons from STZ-treated mice, consistent with
reduced molecular and functional expression of GCK in
the vagal complex of hyperglycemic, STZ-treated mice.
Altered autonomic responses to glucose in type 1 diabetes
may therefore involve reduced functional GCK expression
in the dorsal vagal complex.  2015 IBRO. Published by
Elsevier Ltd. All rights reserved.http://dx.doi.org/10.1016/j.neuroscience.2015.08.023
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Diabetes mellitus, deﬁned by unequivocally elevated
blood glucose levels, aﬀects over 29 million people in
the United States (Centers for Disease Control and
Prevention, 2014). Some of the serious complications of
diabetes include heart disease, stroke, hypertension,
blindness, nervous system damage, and gastrointestinal
dysfunction. Treatments for the disease remain inade-
quate, despite substantial investment to reduce symp-
toms and complications of the disease. Multiple
‘preautonomic’ areas of the brain contribute to systemic
glucose homeostasis (Zsombok and Smith, 2009;
Kalsbeek et al., 2010; Yi et al., 2010) and are also
aﬀected by elevated blood glucose levels. In particular,
neural circuits in the hindbrain play a critical role in regu-
lating plasma glucose and insulin levels. More speciﬁ-
cally, vagally-mediated parasympathetic output critically
regulates visceral functions related to metabolic home-
ostasis, and abundant evidence indicates that the brain-
stem dorsal vagal complex plays a primary and critical
role in glucose-sensitive modulation of plasma glucose
and insulin levels, feeding, and energy balance (Ritter
et al., 1981; Laughton and Powley, 1987; Ritter et al.,
2000; Zsombok and Smith, 2009).
Neurons in the brainstem nucleus tractus solitarius
(NTS) receive glutamatergic, primary vagal aﬀerent
synaptic input from the gut and other thoracic and
abdominal viscera. Vagal aﬀerents rapidly convey
information about gastrointestinal distention and nutrient
content to the NTS, where that information is
processed, integrated with neuronal and humoral
signals, and transmitted to other brain areas, including
the vagal motor neurons of the dorsal motor nucleus of
the vagus (DMV). Neurons in the NTS respond to
acutely altered glucose concentration with either
increases or decreases in neural excitability and altered
synaptic input (Oomura et al., 1974; Balfour et al., 2006;
Wan and Browning, 2008; Lamy et al., 2014; Boychuk
et al., 2015a), which are glucokinase (GCK)-dependent.
The depolarizing response is mediated by inactivation of
ATP-sensitive K+ (KATP) channels (Balfour et al., 2006;
Boychuk et al., 2015a) and KATP channel modulation pre-
vents the glucose-induced, GABA-mediated inhibition of
vagal motor neurons (Ferreira et al., 2001). Type I
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due to reduced insulin secretion from pancreatic beta
cells. Synaptic and other cellular responses in the dorsal
vagal complex are altered in models of type 1 diabetes,
even after normalizing glucose concentration (Zsombok
et al., 2011; Browning, 2013; Blake and Smith, 2014;
Bach et al., 2015; Boychuk et al., 2015b). Vagal reﬂexes
are often blunted during chronic hyperglycemia, and
altered vagal function may contribute to diabetes-
associated visceral dysfunction (Saltzman and
McCallum, 1983; Undeland et al., 1998), suggesting that
chronically-elevated glucose alters responsiveness of
neurons in the dorsal vagal complex.
Because of the involvement of GCK and KATP channel
modulation in the neuronal response to glucose, and the
altered responsiveness of NTS neurons in animal
models of type 1 diabetes, we tested the hypothesis
that GCK or KATP channel expression is altered after
several days of chronic hyperglycemia/hypoinsulemia in
the streptozotocin (STZ)-treated mouse. Understanding
how glucose sensitivity in the dorsal brainstem is altered
in diabetes may oﬀer hypotheses to guide the
development of alternative therapies for the disease.EXPERIMENTAL PROCEDURES
Animals
Mice were treated and cared for in accordance with the
National Institutes of Health Guide for the Care and Use
of Laboratory Animals, and all procedures were
approved by the University of Kentucky Animal Care
and Use Committee (Animal Welfare Assurance
Number A3336–01). Euthanasia was accomplished by
anesthesia with isoﬂurane to eﬀect (IsoThesia; Henry
Schein, Melville, NY, United States), followed by
decapitation while anesthetized. Juvenile and young
adult (28–42 days) male CD-1 (Harlan Laboratories,
Indianapolis, IN, United States) or transgenic ‘GIN’ mice
(FVB-Tg (GadGFP) 4570Swn/J; The Jackson
Laboratory, Bar Harbor, ME, United States) were used
for all experiments and housed under a standard 14-h
light-10-h dark cycle, with food and water provided
without restriction. The GIN mice express enhanced
green ﬂuorescent protein (EGFP) in a subset of GABA
neurons in the NTS, which comprise a large proportion
of NTS neurons (Oliva et al., 2000; Williams and Smith,
2006; Glatzer et al., 2007; Boychuk et al., 2015a).STZ injection
Intra-peritoneal injection of STZ (200 mg/kg in 0.9%
NaCl), which kills insulin-secreting pancreatic b cells,
was used to induce chronic hyperglycemia in mice.
Blood glucose concentration (non-fasted) was measured
by tail puncture using a Nova Max PLUS glucometer
from normal mice, which were then fasted for 4–6 h
prior to STZ or vehicle injection. Control mice were
either injected with saline (0.9% NaCl) or untreated. No
diﬀerences in electrophysiological parameters were
observed between normoglycemic saline-injected and
untreated mice; they were therefore pooled andconsidered as a single control group. Blood glucose
levels (non-fasted) were measured daily. Onset of
hyperglycemia (i.e., blood glucose concentration above
300 mg/dl) varied between animals, but occurred
between 1 and 3 days post-STZ injection and remained
elevated until the day of the experiment. Animals were
used for electrophysiological recordings and molecular
analyses after 3–4 days of continuous hyperglycemia.
Brain slice preparation
On-cell and whole-cell voltage-clamp recordings were
made using brain stem slices prepared from male GIN
mice, 4–5 weeks of age. Animals were deeply
anesthetized by isoﬂurane inhalation (IsoThesia; Henry
Schein) and decapitated while anesthetized. The brain
was rapidly removed and blocked to isolate the
brainstem and then glued to a sectioning stage.
Transverse (coronal) brain stem slices (300 lm)
containing the caudal NTS (i.e., ±600 lm rostral and
caudal to area postrema) were made in ice cold,
oxygenated (95% O2–5% CO2) artiﬁcial cerebrospinal
ﬂuid (ACSF) using a vibrating microtome (Vibratome
Series 1000; Technical Products, St. Louis, MO, United
States). The ACSF contained (in mM): 124 NaCl, 3 KCl,
2 CaCl2, 1.3 MgCl2, 1.4 NaH2PO4, 26 NaHCO3, and 11
or 2.5 glucose (pH 7.15–7.3); osmolality was adjusted to
290–310 mOsm/kg with sucrose; equimolar ACSF was
made by substitution of sucrose for glucose substitution
experiments. Slices were incubated for an equilibration
period for P1 h in warmed (30–33 C), oxygenated
ACSF prior to recording.
Electrophysiology
A single brain slice was transferred to a recording
chamber mounted on a ﬁxed stage under an upright
microscope (BX51WI; Olympus, Melville, NY, United
States), where it was continually perfused by warmed
(30–33 C), oxygenated ACSF. EGFP-labeled NTS
neurons were targeted for recording under a 40 water-
immersion objective with ﬂuorescence and infrared-
diﬀerential interference contrast (IR-DIC) optics, as
previously described (Williams and Smith, 2006; Glatzer
et al., 2007; Gao et al., 2009; Boychuk et al., 2015a).
For recordings from EGFP-labeled NTS neurons, initial
visualization was made brieﬂy under epiﬂuorescence
using a ﬂuorescein isothiocyanate (FITC) ﬁlter set (excita-
tion ﬁlter wavelengths: 450–490 nm).
On-cell and whole-cell patch-clamp recordings were
obtained in the NTS using pipettes pulled from
borosilicate glass (Garner Glass, Claremont, CA, United
States; open tip resistance 4–6 MO) using a Sutter P-87
horizontal puller (Sutter Instrument Co., Novato, CA,
United States). Pipettes were ﬁlled with a solution
containing (in mM): 130 K+-gluconate (or
Cs+-gluconate), 1 NaCl, 5 EGTA, 10 HEPES, 1 MgCl2,
1 CaCl2, 3 KOH (or CsOH), 2–4 ATP (pH 7.15–7.3).
Electrophysiological signals were recorded using a
MultiClamp 700B ampliﬁer (Molecular Devices,
Sunnyvale, CA, United States), low-pass ﬁltered at
3 kHz, and recorded onto a PC-style computer (Digidata
1440A, Molecular Devices) using pClamp 10.2 software
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on-cell recordings. For whole-cell voltage-clamp
recordings, series resistance was monitored throughout
the recordings and data were used for analysis if the
series resistance remained <25 MO and changed by
620% during the recording. Once a recording was
obtained, cells were allowed to equilibrate for 10 min
before beginning data collection.
In whole-cell voltage-clamp recordings, resting
potential was determined by monitoring the voltage at
which no current was injected. Spontaneous excitatory
postsynaptic currents (sEPSCs) were examined at a
holding potential of 65 mV and inhibitory postsynaptic
currents (sIPSCs) were examined at 0 mV using pipettes
containing Cs-gluconate to block K+ currents, thereby
improving voltage control and reducing noise. Miniature
EPSCs and IPSCs (mEPSCs and mIPSCs) were
recorded in the presence of tetrodotoxin (TTX; 2 lM).
The GCK inhibitor glucosamine (GA; 5 lM; MP
Biomedical, Santa Ana, CA, United States) was applied
with the ACSF for 10 min. For eﬀects of elevated glucose
concentration, slices were incubated in ACSF containing
2.5 mM glucose for at least 1 h prior to on-cell recording.
Spontaneous action potential activity was recorded for
10 min prior to changing to ACSF containing 15 mM
glucose for 10 min before returning to 2.5 mM glucose
solution (washout). Recordings of 2–3-min epochs were
made prior to and after 10 min of GA- or 15 mM glucose-
containingACSFapplication.Washoutwas at least 15 min.
RNA isolation
Brainstem slices (300 lm) from male CD-1 or GIN mice
were isolated in cold ACSF, as described for
electrophysiological recordings. The dorsal vagal
complex, including most of both the DMV and NTS, was
visualized under a dissecting microscope and excised
from the rest of the brainstem with a 1-mm diameter
biopsy punch (Miltex, Inc. York, PA, United States).
Resulting punched-tissue was then suspended in 500 ll
of TRIzol (Sigma–Aldrich, St. Louis, MO, United States)
and gently shaken periodically for 5 min. Chloroform
(100–250 ll) was added and tubes were vortexed for
15 s, maintained at 4 C for 20 min, and subsequently
centrifuged at 12,000 rpm for 15 min at 4 C. The pellet
was discarded and the supernatant containing RNA was
transferred into fresh 1.5 ml centrifuge tubes, mixed with
500 ll of ice-cold propanol, incubated at room
temperature for 10 min, and centrifuged at 12,000 rpm
for 10 min at 4 C. Propanol was decanted and RNA
was washed by re-suspension in 500 ll 75% ethanol
followed by centrifugation at 7500–12,000 rpm for
10 min at 4 C. The wash step was repeated, the
ethanol decanted, and RNA samples were air-dried for
10–20 min. RNA samples were re-suspended in 8–10 lL
RNAse-free water and stored at 80 C or immediately
reverse-transcribed into cDNA.
TaqMan quantitative reverse transcriptase-
polymerase chain reaction (RT-PCR)
RNA samples were reverse transcribed in reverse-
transcription (RT) master mix containing: 1 ll randomnonamers (50 lM; Sigma–Aldrich), 5 ll MMLV RT buﬀer
(5) (Fisher Scientiﬁc, Pittsburgh, PA, United States),
5 ll dNTPs (10 mM; Fisher), 2 ll DEPC-treated H2O
(Fisher), 1 ll reverse transcriptase (Fisher), and RNAse
inhibitor (1 ll; Fisher) in a thermocycler (Mastercycler,
Eppendorf) at 42 C for 90 min followed by 5 min at 95 
C. Negative controls included no template and RNAse-
free sterile water instead of template. No RNA was
detected in these controls. Primers and probes were:
b-actin, Bactin, NM_007393 Actb; SUR1, Abcc8
NM_011510; and Kir6.2, Kcnj11, NM_001204411
(Integrated DNA Technologies, Coralville, IA, United
States) and GCK, NM_010292.4 (Sigma). Master mix
included 10 ll of TaqMan Universal master mix II
(Applied Biosystems, Life Technologies, Grand Island,
NY), 1 ll of primer/probe mix and 9 ll Of cDNA
+ RNAse-free sterile H2O. Samples were loaded into a
96-well plate (Bio-Rad, Hercules, CA, United States).
Samples were centrifuged for 2 min at 1000 rpm and
placed in an Applied Biosystems thermocylcer (ABI 7500)
for PCR analysis. Samples were held at 95 C for 2 min
and cycled 50 times at 95 C for 30 s, 60 C for 15 s and
at 72 C for 15 s. Gene transcript level from each mouse
was measured in triplicate; target transcript cycle
threshold (CT) value was normalized to the CT value for
b-actin for each sample; resulting diﬀerence CT (dCT)
values were compared statistically. Results were also
analyzed by the 2ddct method (Livak and Schmittgen,
2001). Diﬀerences of p< 0.05 were considered signiﬁcant.
Western Blots
Brainstem slices (300 lm) were cut as described above,
the dorsal vagal complex was isolated from the slice,
and tissue punches containing the DMV and NTS were
immediately transferred to 40–60 ll of lysis buﬀer
consisting of 0.15 M NaCl, 5 mM EDTA (pH 8), 1%
Triton X-100, 10 mM Tris–HCl (pH 7.4), 10 ll/ml of
100 mM phenylmethylsulfonyl ﬂuoride (PMSF;
174.2 mg/10 ml in methanol), and 100 ll/ml of 0.5 M
NaF (pH 10). Each sample was sonicated and
centrifuged immediately at 12,000 rpm for 3 min.
Supernatant was aspirated, aliquoted, and stored at
80 C until further use. Protein concentration was
measured using a Bradford Protein Assay and 20 lg of
protein was loaded per lane for Western blot analysis.
The appropriate volume of sample together with equal
amounts of loading buﬀer was boiled in water for 2 min.
Samples and ladder were loaded into precast SDS
polyacrylamide gels and electrophoresed at 50 mA for
45–80 min. Proteins were then transferred at 200 mA for
2 h onto polyvinylidene diﬂuoride membranes for
Western blot analysis. Membranes were blocked in 1:1
Odyssey (Li-Cor Biosciences, Lincoln, NE, United
States) blocking buﬀer/TBS/0.1% Tween 20 for 1 h at
room temperature. Due to well-separated molecular
weights of the GCK (band at 65 kD) and b-actin (band
at 40–45 kD) protein membranes were cut in half and
incubated over-night at 4 C, with a rabbit monoclonal
anti-GCK (1:1000; Abcam, Cambridge, MA, United
States) and a rabbit monoclonal anti-b-actin (1:10,000;
Abcam) antibody in Odyssey blocking buﬀer/TBS/0.1%
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TBS on a shaker and treated for 1 h with ﬂuorescence-
conjugated anti-rabbit IgG (IRDye 680RD; Li-Cor
Biosciences). Membranes were then washed (4  5 min)
and scanned on a densitometer (Odyssey model 9120,
Li-Cor Biosciences) to quantify band density.
Background density was subtracted from the GCK band
density and normalized to b-actin, which was used as a
loading control.Fig. 1. Expression of glucokinase (GCK) and ATP-sensitive K+
(KATP) channels in the dorsal vagal complex of normoglycemic control
and hyperglycemic, streptozotocin (STZ)-treated mice. (A) Molecular
expression of GCK mRNA was signiﬁcantly reduced in the dorsalData analysis
Recordings were analyzed using Clampﬁt 10.2 (Molecular
Devices) and MiniAnalysis 6.0.7 software (Synaptosoft,
Decatur, GA, United States). At least 2 min of
continuous recording under each condition was used to
assess mean action potential frequency or EPSC and
IPSC frequency and amplitude. The Kolmogorov–
Smirnov (K–S) intra-assay test was used to determine
statistical signiﬁcance of drug- or glucose-induced
changes in the frequency of action potentials, EPSCs,
or IPSCs within a recording. For all electrophysiological
experiments, a two-tailed Student’s t-test was used to
identify eﬀects within neurons; a two-tailed Chi-square
test was used to compare proportions of responding
cells between STZ-treated and saline-treated mice
(Graphpad Prism, San Diego, CA, United States). For
quantitative RT-PCR and Western blots, an unpaired
Student t-test was used to detect diﬀerences between
samples from each group. Values are presented as
mean ± SEM; statistical signiﬁcance for all measures
was set at p< 0.05.vagal complex of STZ-treated mice after 3–4 days of chronic
hyperglycemia versus control mice (p< 0.05; n= 8 for each group).
Expression of Kir6.2 and SUR1, components of the KATP channel,
were not signiﬁcantly altered (p> 0.05). (B) Western blot analysis
indicated that GCK protein expression was lower in the dorsal vagal
complex of STZ-treated mice (n= 8) than controls (p< 0.05; n= 8).
Inset: Sample blot of b-actin and GCK protein expression from control
and STZ-treated mice; center lane is protein ladder. Asterisks
indicate p< 0.05.RESULTS
Molecular expression of GCK and KATP channels
Punches of tissue containing the dorsal brainstem were
collected from normoglycemic (n= 8; glucose index
180 ± 4 mg/dl) and STZ-treated CD-1 mice that were
hyperglycemic for 3–4 days (n= 8; 469 ± 5 mg/dl). All
target transcript measurements were normalized to
b-actin expression. Quantitative RT-PCR revealed a
signiﬁcant decrease in GCK expression in the dorsal
vagal complex from STZ-treated hyperglycemic CD1
mice versus controls (p< 0.05; Fig. 1). GCK expression
was similarly reduced in the vagal complex of GIN mice
(n= 5 control, n= 7 STZ-treated; p< 0.05). No
signiﬁcant expression diﬀerences were detected for
Kir6.2 or SUR1 transcripts between normoglycemic and
hyperglycemic CD-1 mice (p> 0.05; Fig. 1). Molecular
expression of GCK, but not components of the KATP
channel, was reduced in STZ-treated, hyperglycemic
mice relative to control mice.
To determine if the decrease in mRNA transcription
correlated with decreased protein expression, Western
blots were performed on punches from an additional
eight control and eight STZ-treated hyperglycemic CD-1
mice. Western blot analysis indicated that GCK protein
expression was signiﬁcantly reduced in the dorsal vagal
complex of STZ-treated hyperglycemic mice (p< 0.05;
Fig. 1).Eﬀect of GCK inhibition on synaptic input to NTS
neurons
GCK inhibition prevents responses to acute hypoglycemia
in a subset of GABAergic NTS neurons (Lamy et al.,
2014). Since GCK expression was reduced in the NTS
of STZ-treated mice after several days of hyperglycemia,
responses to the GCK inhibitor, GA (5 lM) were deter-
mined in GABAergic medial NTS (mNTS) neurons, iden-
tiﬁed by expression of EGFP in acute slices from
normoglycemic control (n= 5) and STZ-treated GIN mice
(n= 5). In GABAergic mNTS neurons from normal mice,
GA application decreased the frequency of sEPSCs by
P20% in 80% of neurons (12 of 15 neurons; 2.83
± 0.34 Hz control ACSF; 1.72 ± 0.22 Hz in GA;
n= 15; p< 0.05; Fig. 2), with no change in sEPSC fre-
quency in the remaining three neurons. No eﬀect on
synaptic current amplitude was detected (p> 0.05). In
the presence of TTX (2 lM) to prevent action potential ﬁr-
ing, there was no signiﬁcant eﬀect of GA on miniature
EPSC (mEPSC) frequency in control mice (p> 0.05);
Fig. 2. Modulation of synaptic responses in NTS neurons by
glucosamine (GA). (A) Graph showing the relative overall eﬀect of
GA on sEPSCs and sIPSCs in GABAergic mNTS neurons from
control and STZ-treated mice (n= 6–15). sEPSC frequency was
suppressed in the presence of GA in 80% of neurons from control
mice, but GA was generally without eﬀect on sEPSC frequency in
most neurons (83%) from STZ-treated mice. Asterisk indicates
signiﬁcant diﬀerence from control group for sEPSC frequency. Eﬀects
of GA on sIPSCs were variable in both control and STZ-treated mice.
(B) Pie graphs indicating the percentage of neurons in which GA
application evoked aP20% change in frequency of either sEPSCs or
sIPSCs in mice from each treatment group.
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ﬁve neurons from three mice, so eﬀects in STZ-treated
mice were not assessed. These ﬁndings are consistent
with an eﬀect of GCK in mediating spontaneous excitatory
synaptic responses to ambient glucose levels in NTS neu-
rons (Wan and Browning, 2008) and indicated that GCK
blockade inhibited excitatory, glutamatergic synaptic input
to most GABA neurons.
In GABAergic mNTS neurons from STZ-treated mice
after 3–5 days of hyperglycemia (n= 5), eﬀects of GA
on sEPSC frequency were signiﬁcantly less robust than
in controls (p< 0.05; Chi-square), being reduced
(22%) in only one of six neurons and unchanged in
the remaining ﬁve cells (Fig. 2). Overall, mean sEPSC
frequency was unchanged in the presence of GA (7.63
± 1.04 Hz in control ACSF; 7.04 ± 0.83 Hz in GA;n= 6; p> 0.05). Consistent with the decreased GCK
expression in the vagal complex, modulation of
excitatory synaptic activity by GA was reduced in
GABAergic mNTS neurons from STZ-treated,
hyperglycemic mice.
Eﬀects of GA application on sIPSC frequency and
amplitude were also determined. In GABAergic mNTS
neurons from control mice (n= 5), GA application was
without eﬀect on the overall population (1.22 ± 0.2 Hz
control, ACSF; 1.25 ± 0.30 Hz, GA; n= 9; p> 0.05),
but was either increased (n= 3) or decreased (n= 6)
in individual neurons (Fig. 2). The amplitude of sIPSCs
was unchanged by GA (p> 0.05). Similar to results in
control mice, there was no overall eﬀect on sIPSC
frequency in neurons from STZ-treated mice (1.04
± 0.30 Hz control ACSF; 1.01 ± 0.31 Hz GA; n= 7;
p> 0.05). sIPSC amplitude was also unchanged
(p> 0.05). In neurons from STZ-treated mice, GA
application either increased (n= 3), decreased (n= 2)
or was without eﬀect (n= 2) on sIPSC frequency
(Fig. 2). There was no signiﬁcant eﬀect of GA on
mIPSC frequency in control mice; mIPSC frequency
was increased slightly in only two of ﬁve neurons from
four mice, so eﬀects in STZ-treated mice were not
assessed. Although sIPSC frequency in GABAergic
mNTS neurons was usually altered by GA application,
robust diﬀerences between responses in neurons from
control and STZ-treated mice were not observed
(p> 0.05; Chi-square).Glucose eﬀect on action potentials
Neurons in the NTS are glucose sensors, and this
sensitivity may be especially prominent in GABAergic
NTS neurons (Ferreira et al., 2001; Lamy et al., 2014;
Boychuk et al., 2015a). Since GCK expression was
reduced in the NTS of STZ-treated mice after several
days of hyperglycemia, we examined action potential fre-
quency of GABAergic NTS neurons in response to elevat-
ing glucose from 2.5 to 15 mM using on-cell recordings.
Increasing glucose concentration resulted in a >20%
change in action potential frequency in 77% of neurons
(10 of 13 cells) from normoglycemic control mice
(n= 6). Increasing glucose concentration resulted in an
increase in action potential frequency in seven of 13 neu-
rons (122 ± 57% increase; Fig. 3), a decrease in three
neurons (27 ± 2% decrease), and no change in three
neurons. In neurons from STZ-treated, hyperglycemic
mice (n= 6), elevating glucose resulted in a change in
action potential frequency in only ﬁve of 15 neurons
(33%), a signiﬁcantly lower percentage of responses than
in neurons from control mice (p< 0.05, two-tailed Chi-
square). The frequency of action potentials was increased
in three neurons (111 ± 22%), decreased in two cells
(55 ± 10%), and was unaﬀected in the remaining 10
cells. Whereas increasing glucose concentration resulted
in a signiﬁcant and large change in action potential fre-
quency in the majority of neurons in normoglycemic mice,
action potential frequency in most neurons from hyper-
glycemic mice was unaﬀected by increasing glucose
concentration.
Fig. 3. Eﬀects of elevated glucose on sodium currents (action
potentials) in NTS neurons from control and STZ-treated mice. (A)
Examples of on-cell recordings in GABAergic mNTS neurons from
control (upper) and STZ-treated (lower) mice showing spontaneous
action potential (sodium current) activity in ACSF containing 2.5 mM
glucose, 15 mM glucose, and after a 15-min wash to 2.5 mM glucose.
(B) Pie graphs indicating the proportion of neurons (n= 13 control;
n= 15 STZ-treated mice) that responded with an increase,
decrease, or no change in action potentials when glucose concen-
tration was elevated. Glucose elevation most often increased action
potential ﬁring in neurons from control mice, whereas the ﬁring rate
was unchanged in most neurons from STZ-treated mice.
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Neurons in the NTS receive direct input from the primary
viscerosensory vagal aﬀerents and comprise the initial
response component of central parasympathetic
regulatory circuits. Subsets of these neurons, and
GABA neurons in particular, are known to be glucose-
sensitive (Oomura et al., 1974; Balfour et al., 2006;
Wan and Browning, 2008; Browning, 2013; Lamy et al.,
2014; Boychuk et al., 2015a). Several physiological
aspects of central vagal circuitry are altered functionally
in diabetes (Zsombok et al., 2011; Browning, 2013;
Blake and Smith, 2014; Bach et al., 2015; Boychuk
et al., 2015b), consistent with modiﬁed parasympathetic
regulation of the viscera concurrent with the disease
(Saltzman and McCallum, 1983). Glucose sensing in
NTS neurons involves GCK, which catalyzes the conver-
sion of glucose to glucose-6 phosphate in neurons and
other cells (Balfour et al., 2006; Briski et al., 2009), result-
ing in increased ATP/ADP ratio. In several neural sys-
tems, membrane responses after increased glucose
concentration are caused by ATP binding to KATP chan-
nels to aﬀect changes in membrane potential. Diabetes
induces changes in GCK or KATP channel expression in
speciﬁc hypothalamic nuclei (Levin and Dunn-Meynell,
1998; Nishio et al., 2006), which are consistent withaltered or compensatory neuronal responses to
chronically-elevated glucose or hypoinsulinemia in
STZ-treated rats. Altered electrophysiological responsive-
ness of NTS neurons in type 1 diabetes has been demon-
strated (Browning, 2013; Bach et al., 2015), which could
contribute to visceral dysregulation in diabetes, but the
mechanisms of this plasticity are unknown. Here, we
found that molecular and functional expression of
GCK—but not components of the KATP channel—were
diminished in the vagal complex of mice with type 1 dia-
betes. Consistent with decreased mRNA transcription,
GCK protein levels were reduced, neuronal and synaptic
responses to GCK blockade were attenuated, and neu-
ronal activity responses to increased glucose concentra-
tion were diminished. A similar decrease in GCK
expression and activity has been reported in the arcuate
nucleus, but not in other glucose-responsive hypothala-
mic nuclei, of STZ-treated rats (Nishio et al., 2006). The
present ﬁndings suggest that responses of NTS neurons
to increased glucose concentration may be altered as a
consequence of chronic hyperglycemia or hypoinsuline-
mia in a GCK-dependent manner, similar to glucose-
sensitive neurons of the arcuate nucleus.
Neurons in the NTS normally respond to elevated or
reduced glucose concentration with either increases or
decreases in excitability (Oomura et al., 1974; Balfour
et al., 2006; Wan and Browning, 2008; Browning, 2013;
Lamy et al., 2014; Boychuk et al., 2015a), which are often
GCK-dependent. Glucose-induced increases in excitation
are mediated by inactivation of KATP channels in NTS
neurons (Balfour et al., 2006; Boychuk et al., 2015a)
and KATP channel modulation prevents the glucose-
induced, GABA-mediated inhibition of vagal motor neu-
rons (Ferreira et al., 2001). We tested the hypothesis that
expression of molecular components of the KATP channel
was altered after several days of hyperglycemia. KATP
channels in central neurons are mainly composed of
SUR1 and Kir6.2 subunits and SUR1 is expressed by
glucose-sensing NTS cells (Balfour et al., 2006). In
STZ-treated rats, SUR binding is increased in neurons
of the dorsomedial, ventromedial, and lateral—but not p
araventricular—hypothalamic nuclei after seven days of
hyperglycemia (Levin and Dunn-Meynell, 1998), suggest-
ing increased KATP channel expression that may serve a
compensatory function in speciﬁc neurons. We found that
molecular expression of SUR1 and Kir6.2 was unchanged
in the vagal complex of mice with type 1 diabetes, which is
inconsistent with the hypothesis that SUR1 activity
increases in the NTS after several days of chronic
hyperglycemia.
Since KATP channel-mediated responses to glucose in
the NTS require GCK, the decrease in GCK expression
suggests a mechanism for blunted responsiveness to
glucose that has been proposed to occur in chronically
hyperglycemic mice (Browning, 2013). The decreased
molecular and protein expression of GCK we observed
was consistent with an attenuation of the electrophysio-
logical response to GCK inhibition. Blockade of GCK
activity resulted in altered synaptic excitability of most
GABAergic NTS neurons from normoglycemic mice, and
this eﬀect was mainly action potential-dependent,
K. C. Halmos et al. / Neuroscience 306 (2015) 115–122 121consistent with tonic GCK-mediated eﬀects on neuronal
activity in the slice. Notably, it is conceivable that
blockade of GCK activity might deplete energy supplies.
This potential confound is mitigated, however, by the fact
that application was limited to 10 min in this study. Fur-
ther, postsynaptic current amplitude was not altered by
GA, suggesting that neural responsiveness was not
overtly aﬀected. The eﬀects of blocking GCK were
reduced in neurons from mice with type 1 diabetes, espe-
cially on action potential-dependent glutamate release,
suggesting that GABAergic NTS neurons may be less
responsive to excitatory synaptic input in mice with type
1 diabetes. Moreover, responsiveness of GABAergic
NTS neurons to increased glucose concentration was
attenuated in STZ-treated, hyperglycemic mice. This fur-
ther implies that synaptic activity in the NTS normally
occurs in the context of glucose concentration, since
GCK mediates glucose-responsiveness in these neurons.
Previous studies indicated that responses of NTS
neurons to acute hypoglycemia required GCK activity
(Balfour et al., 2006; Lamy et al., 2014). Responses to
transient hypoglycemia were previously reported in NTS
neurons that expressed glucose transporter 2 (GLUT2)
and the expression of the transporter was colocalized in
a subset of GABA neurons (Lamy et al., 2014). We
recently showed that GABA neurons were either depolar-
ized or hyperpolarized by glucose, and the depolarization
in particular was sensitive to blockade of GCK activity or
by blocking KATP channels (Boychuk et al., 2015a). Here,
we found that attenuated neuronal responses to transient
hyperglycemia in mice with type 1 diabetes coincided with
reduced molecular, protein, and functional GCK expres-
sion in the vagal complex, suggesting that prolonged
hyperglycemia aﬀects glucose responsiveness in the
vagal complex.
Elevated glucose concentration increases
glutamatergic synaptic transmission from vagal aﬀerents
in rats and mice, and these eﬀects were reported to be
attenuated in a model of type 1 diabetes (Browning,
2013). Our results are consistent with this report, and oﬀer
a mechanistic explanation for the loss of response. The
glucoregulatory response to nutritive substances applied
in the intestine is prevented by blocking ionotropic gluta-
mate receptors in the NTS (Wang et al., 2008; Cheung
et al., 2009), suggesting that glutamatergic, vagal aﬀerent
activation of NTS neurons is required for this response.
Blockade of NMDA receptors in the vagal complex pre-
vents the positive eﬀect of bariatric surgery on systemic
blood glucose levels, an eﬀect hypothesized to occur by
inhibiting a ‘‘gut-brainstem-liver” circuit in the vagal com-
plex (Verberne et al., 2014).
Our results support the hypothesis that diminished
GCK expression in the vagal complex of mice with type
1 diabetes results in reduced responsiveness of NTS
neurons to glucose, including the response to synaptic
glutamate release. It is likely that glutamatergic, visceral
aﬀerent synaptic input to the NTS, including input
mediating mechano- and chemoreceptor activity in the
gut (Barber and Burks, 1987), occurs in the context of glu-
cose concentration. Restoring GCK expression may help
restore physiological responsiveness of NTS neurons toglucose, thereby helping to normalize parasympathetic
regulation of visceral function, including glucose home-
ostasis, in diabetes.Acknowledgement—Supported by NIH grants R01 DK056132
and R21 HD079256.REFERENCES
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